Aspen Neuroscience Gets $70 Million Series A Funding Round

By Steve Adamek

Tuesday, April 14, 2020

Photo courtesy of Aspen Neuroscience. Laboratory workers at Aspen Neuroscience work on Parkinson’s disease treatments.

Photo courtesy of Aspen Neuroscience. Laboratory workers at Aspen Neuroscience work on Parkinson’s disease treatments.

Aspen Neuroscience, a private biotech company developing the first autologous neuron replacement therapy to treat Parkinson’s disease, announced the close of its Series A funding round of $70 million...